https://www2.bdr.riken.jp/renkei/2020/ Takashi Tsuji will hold a lecture on 5. August 2020 11:30-12:30 "Takashi Tsuji Organ regeneration by self-organization of stem cells" - it is a ZOOM conference Does somebody here know a japanese who can participate in this Zoom-conference and share the informations Tsuji will give? @Trichosan is it possible that your wife log in to Tsujis lecture? It is very important that we find a person who will collect the informations about Tsujis lecture! Won't have much more possibilities to watch a Tsuji presentation in the internet! @Fuji Maru Kagurazaka can you please participate in this conference? 生命科学におけるゲノムから個体までの多様な研究対象、研究方法を含め、原理解明から応用へ繋がる理研 生命機能科学研究センター（BDR）神戸キャンパスの先端研究を紹介します。 2020年8月5日（水） https://www2.bdr.riken.jp/renkei/2020/ 11:30-12:30 辻 孝 幹細胞の自己組織化による器官再生
Someone posted the full Tsuji article on Imgur, all we need now is a translator. https://imgur.com/a/kDTPfU @Fuji Maru Kagurazaka
Even if wie cant find a japanese to attend we should try to record bis speech. Then we habe Mord time to find someone to translate.
I've translated it with translator Deepl. Some parts may not be correct. I wondered if this was the case. If the hematopoietic stem cells, which were being developed at Niigata University, could be turned into a drug for treating autologous blood disorders, it would certainly be a cure for autologous blood disorders. However, the company's top management decided not to develop the drug, fearing that it might be contagious if it used human cells. Descent. is the row that would later lead to making stem cell-based therapy, or regenerative medicine, a life's work. After finishing his doctoral studies in 1973, he joined Japan Tobacco Inc. and was assigned to the Life Science Institute in Yokohama, Japan. Then, he was hired a year earlier, and he immediately hit it off with Yasuhiro Fudwara (currently a professor at Osaka University), who was three years younger than him. He immediately got along with Yasuhiro Fudwara (currently a professor at Osaka University), who had joined the company a year earlier and was three years younger than him. According to Toshihara, Tsuji was friendly, without being "too old for him". They had one thing in common, too: they were both sons of local shopkeepers and had a passion for fishing. Both were sons of local shopkeepers and had an unparalleled love of fishing. After a year of lively discussions about research and research, Kajiwara was transferred to Yokohama City University and Tsuji was transferred to JT Pharmaceuticals, Inc. He moved to the Discovery Research Institute in Yokohama, Japan, but the Bunryu continued. Tsuji's research focuses on the proliferation of hematopoietic stem cells in the umbilical cord blood of newborn babies in vitro1. At JT, he wrote a paper on hematopoietic stem cells, which became a major beer-boynt. At the University of Science, he taught a course on non-specialized subjects such as pharmacology, chemistry and physiology before he was an undergraduate. The university was blessed with a high level of funding among private schools and its students were serious. However, I was assigned to a laboratory with 10 students per year. I was assigned to a laboratory, which had an annual stipend of ten students, and I had to supervise more than a dozen students, including those in the graduate school. When I was a student at Kyushu University, I felt a sense of tension and a sense of alienation in the Spartan laboratory HeC, but I was the leader of The pressure from the height of purpose and the difficulty of managing a lab with many members when you become a I was confronted with the fact that I was in the same position as Dr. Nakamura. He said, "Having been in the same position, I can now fully understand how Dr. Nakamura felt about his feelings of unity and loneliness. I'm sure that I'll be able to help him more if I'm on my own now, and I'm sure that the relationship with Kajiwara, a colleague of mine from JT, will be very important. This was the beginning of a unique encounter with Otsuka Chemical. This was the point of contact with Otsuka Chemical, which later became a researcher in the regeneration of organs such as teeth and hair. Kajiwara, who specialized in glycoscience, was engaged in research together with Otsuka Chemical. Tsuji was put in charge of the biological evaluation of tambac proteins synthesized by Taxahara and linked with glycolysis, and he was assigned to work with Otsuka Chemical in the field of science and technology. Otsuka Chemical Co., Ltd. entrusted me with its first endowed lecture series at the University of Tokyo, and my original specialty, regenerative medicine, is the study of three-dimensional organs. The aim is to regenerate. The large and complex structures of the liver and other organs are created in accordance with the biological principle, and are covered all over the body surface. If "teeth and hairs are not directly linked to life and death," it would be easier to build an experimental model, so Tsuji quits JT and moves to the University of Science. After immersing himself in research and education, Tsuji decides to leave JT after seven years of service. He had the confidence to think about his research theme, implement it, and write a paper on it. He wanted to take the initiative in researching a new field that would lead to practical applications, and he asked the university to fight for him. At that time, he was appointed as a faculty member of regenerative medicine at the Tokyo University of Science's School of Engineering and Technology and became an assistant professor in 2001. . In the whole industry, patents are more important than papers. I got it. Tsuji is a good presenter. Since his time in the corporate world, he has how to persuade his superiors by using management's words to persuade them. We make sure that all students and staff members, including those who have been working at the University, are fully aware of the importance of greetings, keeping their promises, and beilearnedng organized. This is because he believes in the importance of the researcher as a human being. Mayumi Murofushi, an assistant at Riken, said that a student of hers at Ritsumeikan University T There are a lot of things that are line packed and I have a lot of sympathy for [Tsuji's] beliefs," Aogan said. The company is not only engaged in the field of regenerative medicine, but also in the field of health care. In 2006, he led the world in the development of artificial skin for the evaluation of the safety and functionality of cosmetics and quasi-drugs. It was released. In the midst of the trend of banning animal testing, this product is attracting a lot of attention as the next generation of artificial skin. Tsuji is also aiming to commercialize hair diagnosis. RIKEN has been working on it for some time now, saying, "I understand the words of people in the light industry, and I have a good idea of the seeds that companies are looking for. I'm sure I'll be able to play a role in bridging the gap with companies. In June, Tsuji was appointed to a position at RIKEN, but while he was being held accountable for the research fraud surrounding STAP cells, Sasai's father, a former professor of chemistry at the University of California, Berkeley, was also being held accountable. The loss of his spiritual pillar and supreme mentor, a comrade who took his own life in August of that year, made Tsuji For a short time he was at a loss for words, but Yoi, who was busy with industry and academia, entrusted him with the mission of "fusion cooperation" which was completed in five years. The idea is to attract companies to the Innovation Promotion Mechanism. The external funds obtained from the joint research with Tsuji alone will be used to pay for all the joint research that RIKEN receives from companies. It reached 10%. Like the pre-war science and research centers, it is an independent, self-financing, two-year organization. We aim to pursue our research and collaborate with private companies for the practical application of hair follicle regenerative medicine, and to apply the seeds of our research and Organ Corporation, which was recognized as a "RIKEN Venture", formed a partnership with Kyocera. Kita, who sympathized with Inamori's philosophy, directly contacted the founder of the company, Kazuo Inamori, and signed a contract with him on August 8, 2002. It was cultivated and made more than 5,000 hair follicle taphone-the equivalent of 10,000 hairs. In an experiment in which these were transplanted into mice, the hair regenerated and was replaced for life. It is expected to be a treatment for not only male pattern baldness, but also for intractable hair growth disorders such as congenital Whairui syndrome. On the other hand, in the area of tooth regeneration, Harumei of Tokyo Medical and Dental University and Masao Oshima, an associate professor at the University of Tokushima and a pupil of Tsuji's, have been working with The next generation of "hybrid implants" is under development. The company has been working on the development of a new type of implant to replace missing teeth, which is widely used to attach an artificial tooth to a full alveolar bone. This is not a good treatment. In this case, the artificial root membrane is connected to the alveolar bone through the artificial south root membrane to provide the same physiological function as a natural tooth. Reproduction. The artificial tooth has the advantage of not becoming an orchid and regenerating organs while enhancing their function. The company has already achieved success in experiments on dogs, which have a strong ability to blow together, and is aiming for early commercialization. Tsuji, who is particular about useful research, has been pursuing innovative basic research innovations that will help to make Japan's health. This is the mission of his own. The realization of this mission is my mission. The company is developing a traditional way of doing business. First institutions such as Organ, Yahoo, and Aderans establish a consortium, and joint research is a star". And then the clinical research of the real life hair - a clinical study of about 100 hair follicles taken from Sekikata's scalp. However, he had neither the knowledge nor the research experience on the development of teeth. He was introduced to Kasugai Shohei, a professor of dental implantology, by Kazuhiro Eto, the vice president of Tokyo Medical University. It was made. It's a cloud-grabbing story, and I don't think it's going to be possible," said Kasugai, who was consulted by Tsuji for nine years When these tooth seeds are transplanted into the adultus, the teeth with blood vessels and nerves regenerated for 8 years, the adult mouse's teeth If you plant it in the area where the tooth came out, you'll have a complete set of teeth that will grow back in just over a month, and you'll have a perfect fit and feel the pain. Successful regeneration. Kasugai was taken aback by Ichijitsuji's research sense, and in two years, he succeeded in the regeneration of hair from hair seeds. Because hair grows in a fixed cycle, only two types of stem cells necessary for official regeneration are available in adult organisms. In teeth, a seed for a tooth can only be made from the toothpaste of milkshakes or shui-ku'er. In order to regenerate a tooth in a toothless adult, the stem cells that can be used for tooth regeneration must be deepened, which is one of the barriers to practical use. In his early years, Tsuji founded Organ Technologies, a venture company with the support of Otsuka Chemical. In his early years, Tsuji founded a venture company, Organ Technologies, with the support of Otsuka Chemical. In order to put Tsuji's technology to practical use, a number of patents, including one for the organ germ method, must be consolidated The University of Science and others have filed a pre-patent petition for a patent, and the company needed a box to stock it. The University of Science and others received a pre-application proposal for the patent, and the company needed a box (company) to stock it "passionately and sharply dropped. The "V" is an endowed lecture given by the Organ Corporation in its year of residence, bringing new life to an old company like Otsuka Chemical. In 1996, he became a full-time research professor at the University of Science. In the following year, the University of Science constructed the Organics Regeneration Engineering Project, and it became a major research center of the Organ Corporation. In 2000, the Organ Regeneration Engineering Project was established at the University of Science, and it became a major research center of the Organ Corporation. However, a miscalculation occurred. The support from Otsuka Chemical differed from the original plan and was cut off after 4 years. The business was reviewed. However, Tobe continued to invest in the company privately even after it was separated from Otsuka Chemical, and he continues to meet with Tsuji several times a year. For Tsuji, who was a close friend of Otsuka Chemical's business reports, it was a form of support from Otsuka Chemical. However, a new opportunity opened up for him in a different way. Yoshiki Noui, a leader in regenerative medicine and a former researcher at Riken, invited him to join Kyoto University's Department of Regenerative Medicine for two years. The same age as Noui, who sat with him at a lecture at the institute, was a supervisory stem cell (E) student. Tsuji had been fascinated by RIKEN since his high school days. The history of Riken dates back to before World War II, and Sasai, who had a high standard of research and an air of respectability, told him that Riken was a good place to work. I was invited to be the Group Director, but I turned down the offer twice, thinking I was not suited to the position. In the end, I decided to apply for the position because I wanted senior researchers to be responsible for applications and young researchers to focus on basic research. He shared Sasai's desire for a "tooth", so Tsuji learned about the principle of the development of the South and exchanged ideas with him. He is convinced of the regeneration from the "Tanee" (the original organ of music). He made the base of the organ, the seed, and grew it and regenerated it into a 9-toto organ regeneration and play AK Me. When a clear mammal with a good research sense is in the embryonic stage of development, the seeds of organs needed for a specific location are stem It is made from cells and grows into an organism. Tsuji took a rakugo story from a mouse nodule, which was determined to become a tooth in the future, and created an epithelial stem The cells were paralleled into two types of stem cells and cryptogenic stem cells. These two types of stem cells were combined into a two-layered structure in a single high-degree trial, and the "Southern Seed" type S method was named "Instrumental Palace Method". This led to the success of the revitalization of the government, which was largely due to the wise decision of Otsuka Pharmaceutical Co. Initially, Organ was established as a wholly owned subsidiary of Otsuka Chemical, and Otsuka Chemical was the only company to provide research and development funds to the government. Sadanobu Tobe, then president of the company (now. Otsuka Tobe was overwhelmed by Tsuji's heatsuke in his first game against
@Trichosan I already asked you to help us out and translate the article but you don’t answer. This is sad. Why your wife can’t read the whole article and collect and summarize the interesting facts(we don’t need a translation of every scientific sentence or other blablabla - only filtering important business facts. That should take 10 minutes work for her) Is there some informations given: - when will the human trials start? - about commercial plans? I would be glad if you answer us...
Wouldn't be too sure about that: numeric Date formats are a mess, and how on Earth are they allowed in official Docs is beyond me.... https://en.m.wikipedia.org/wiki/Date_format_by_country
Ok, so i used a different translation tool and here is what i got. It translates some of the parts DeepL missed out on giving us a few more details, but it makes less sense overall. Page 1 Leader in "hair and tooth regeneration". clinical research on regenerative medicine to regenerate human organs will begin soon. The target is the hair and teeth. Jartcosm Asako Tsukazaki, LN Oka Studio Takashi Tsuji, Takashi, Team Leader, Center for Frontier Biosciences, RIKEN Transplant. Unlike AS Ruruya, it is a new approach based on the latest regenerative medicine. Takashi Tsuji will lead the organ guidance research team at the Center for Biological Function Sciences (Koreto City) of RIKEN. As researchers in Japan and overseas are trying to overcome the barriers the practical application barriers of regenerative medicine, Tsuji's research has great potential for widespread application, and is attracting attention. What makes Tsuji unique is that it is not the reason why researchers have long been a faculty member of RIKEN's team, but have been working in the states for the academic year. I am from a national university in a rural area and have no experience studying abroad. He quit his job as a researcher at a pharmaceutical company and went on to a doctoral course at the graduate school, but was frustrated. Good news for men with different hair. Using the technology of regenerative medicine, he got a job at a Fusafuno pharmaceutical company, but the drug candidate he had been studying was discontinued. It's a life of a researcher with a new twist. In 1962, I was born in Mino City, Gifu Prefecture. The organisation will soon start a clinical study to regenerate hair follicles, 10 kilometers away from the city center. This is the world's first regenerative medicine for body organs. The cells that are the origin of the collected hair are cultivated, and a large number of times are increased (organ root line that creates hair). Page 2 Tsuji, helped his family business from the 4th grade. The store was a sales shop, so my job was to collect money. My father, who did not attend ordinary high school, wanted us to study hard and live better lives. Tsuji had a vague idea that he wanted to become a doctor and to serve his country. JPS was a researcher of cancer cells. After the second year of the master's program, he became a researcher at the Central Research Center, which was transferred to Yamanouchi Pharmaceutical (now Astellas Pharma), aiming to contribute to society through medicine, and was thoroughly trained from research manners to how to write reports. After that, Yoshiyoshi Furuichi, who will be the executive officer, argued that "it will not be successful unless we develop a country that can only work on the task in front of us and do research to become the next seed of rice." Science that only comes to you. At the time when it became known that the ES master drug article by S°4 Udo DNA was cut off after leaving the school, the outbreak educator Setsuto Okada's "Life in the test tube" was recommended by the teacher. I read and entered the Faculty of Science, Niigata University, which chose the path of biology, but there is no latest lecture on genetics and molecular biology, and practical training is also a high school lesson such as sketching onion epidermal cells. After spending some time reading a technical book, when I was in the 4th grade, I met Soumi Ii, who I started as a professor from the Tokyo Metropolitan Institute of Clinical Medicine, and knowledge of chemistry is indispensable in a bio-pharmaceutical company. It was a complex that I was from the department of biology and ignorant in chemistry, but I told myself that "I honestly know that I do not know what I do not know, and learn in the field," I absorbed myself in research. After 3 years, I could see the surroundings. Good work requires a research philosophy. I want to do science that is not JA to my society," and think of obtaining a PhD. I was advised to study abroad at company expenses, but I retired to cut off my way out. The doctoral course was Shunichi Nakamura of Kyushu University. The up-and-coming S Kankyo that discovered the breeding factor "HGF" was also attractive. Tsuji was a little shy at first, but he is also an older person, and eventually he was assigned to the practice of running the laboratory. The experience of working people came by researching graduate and undergraduate students, allocating and teaching joint research with medical schools and companies. The laboratory was full of tension and finger-Spartan, reflecting Professor Nakamura's aggressive personality. Tsuji discovered the gene for HGF and realized how interesting the research was. It was also attractive to send Shimori to the world. Regulatory figure that suppresses hepatocyte proliferation SS Discovered in the second year given a national theme. The paper was published as the first author in a leading scientific journal. He continues his research on holidays and late at night, becoming a laboratory. I felt the distance between the laboratory management and the research policy of P Nmura. I intended to do my best, but is it the limit? The future as a researcher who gave up his PhD and left the laboratory with disappointment broke off, and the . After going around Japan's Marine Research career route with the help of my fellow lab members, I finally returned to my alma mater Niigata University. Kazuhiro Mori, the successor to Mitsui, accepted me as a research student. Financially, the junior female at Kyushu University, who I was dating with, gave me the Fukuoka S next day. When I was in my second year in Niigata, I married this woman. Mori's research theme was cells of blood cells, especially hematopoiesis. If you look at how blood cells are created from stem cells in an environment that mimics the environment of bone marrow, you can see the origin of the life-rich wealth S. After this experience, in the 3rd year of the Ph.D. After the doctoral course, he started working for Japan Tobacco Inc. (JT) in the year, when he started to use stem cells for treatment, that is, regenerative medicine as his lifework. I was assigned. Therefore, I quickly got along with Yasuhiro Kajiwara (now a professor at Osaka University) who joined the company one year earlier. According to Kajiwara, who is three years younger, Tsuji felt he was older. Although the common points are also emphasized, JT has written two hematopoietic stem Cells papers, which has become popular.. At the University of Science, I was also in charge of lectures for non-specialized subjects such as pharmacology and physiology for undergraduate students. In my private school, I was blessed with research funds and the students were serious. However, there are many people who think that almost 0 people a year in the laboratory|S will be able to do S without having to supervise more than 0 students if the graduate school is included in the distribution.” In my research, I was in contact with Otsuka Kagaku, a colleague from the JT era, who is a sponsor of JS Tsunagata S, who has made an important encounter with S. Kajiwara, who specializes in glycoengineering, made a joint research with Otsuka Chemical Co., Ltd. For the biological evaluation of the fungus that was synthesized by Kajiwara and bound to a sugar chain, Tsuji became Gangawa and RriA, and the first endowment course at Science University was set up at Otsuka Chemical. If hematopoietic stem cells that Niigata University had been working on could be made into a cell drug, it would be a therapeutic drug for leukaemia. However, the upper management of the company was transferred to the University management, where it was decided that the development would be postponed due to the risk of infection of humans and non-S-like artifacts. I was not absorbed in research and education. I felt enthusiastic and exhausted in the Kyushu University Sulta style laboratory, but I faced the pressure from the height of PARAJm to become a leader and the difficulty of running a laboratory with many men J ° "When I went to the ED field, I felt painful about Professor Nakamura's feelings of mission and loneliness. I went fishing in the direction of Izu, and bloomed for fishing and research discussions. A year later, Kajiwara moved to Yokohama City University by moving to the JT Pharmaceutical Research Institute (Yokohama City), but the exchange Tsuji was disappointed with the newborn baby's winning zone.Tsuji sent JT who worked for 7 years. I wanted to get a job from the university.” J Ji S, Toki University of Science received a recruitment of faculty members for regenerative medicine and became an assistant professor in 2001. In the field of regenerative medicine, where patents are the specialty of companies rather than papers, the aim was to regenerate a three-dimensional device. Large and complicated organs such as the liver and kidneys are highly difficult. If organs are created according to the same biological principle and teeth that do not come to life closely to the gyrus in the body surface (the blood of the crotch) and hair blood stem cells proliferate in vitro, If you can help the teacher, you can easily set up an experimental model Page 3 He had neither knowledge of tooth development nor research experience. In the second year, Kazuhiro Eto, who was the vice president of the Tokyo Medical and Dental University, introduced Professor Shohei Kasugai of the Department of Implantology. Kasugai, who was consulted by Tsuji, said, "I wouldn't be able to get S with a cloud-grabbing distance." In 8 years, when this tooth seed was transplanted into an adult mouse, the tooth with blood vessels and nerves regenerated. In 19 years, when it was planted on the part where the tooth of an adult mouse was missing, the tooth grew in about a month more S. Succeeded in completely regenerating teeth that can be engaged and feel pain. Kasugai hates Tsuji's sense of research. 2 years 2 also succeeded in hair regeneration from the SA shape. Hair grows at regular intervals, so in adult teeth, which can form only two types of stem cells required for organ regeneration, tooth seeds can be made only from the history of milk teeth or permanent teeth. In order for adults who have lost teeth to regenerate teeth, they must search for stem cells that become teeth, which is a barrier to practical use. %% of the time, Tsuji received the support of Otsuka Chemical and founded a venture company, Organ Tech Heroes. In order to put Tsuji's technology into practical use, it is required that JSV S patents, which are the organ primordial method, have been collected. I received a pre-application transfer of a patent from the University of Science and needed a box (company) to keep stock. AJ Tsuji learned the principle of tooth generation and exchanged opinions, and he said, “Tooth seeds” I am convinced that it will be regenerated from "°". Totototo grows and regenerates the original material (seeds) that is the basis of separation. Organisms are regenerated and the sensitivity of Pukor AK research is clear. In the development stage, the fetus AJ, which is a developing stage, is made up of stem cells that form the necessary organ seeds and grows into organs. Tsuji extracted the tooth history, which was determined to become a tooth in the future, from the fetus of a mouse and separated into epithelial stem cells and mesenchymal stem cells. These two types of stem cells were made into a high-density two-layer structure to regenerate "tooth seeds". This method was named “Organ Primitive streak Method”, and it led to the success of organ regeneration thereafter. The company was established for the first time as a 1008 subsidiary of Otsuka Chemical. Regarding the provision of R&D funds, Sadanobu Tobe (currently Otsuka Foods Director), who was the president of Otsuka Chemical, had a strong opinion. Tobe is overwhelmed by Tsuji's hot valve that he met for the first time. “I can understand the words of the manager, and I have a sense and idea about the seeds that a company wants. It may be an appropriate role if it is a bridge with a company.” Since he was a company with good presentations, Tsuji has been able to persuade his boss in the words of the owner to hang his heart. With H as KAN, we thoroughly implement business manners such as greetings, compliance with promises, and tidying up. From the belief that a person is a researcher and is a member of society in R. Mayumi Murofushi, an assistant at RIKEN, was a student at the University of Science, saying, "Many people are unable to greet people, and many of them (in Tsuji's belief) can feel empathy invited to RIKEN. Sasai's death and death after academia, Tsuji joined RIKEN in April 1st, but Sasai lost his life in the month of this year as he was blamed for research fraud over STAP cells. Although Tsuji's morale of the best leader P was lost, and Tsuji tended to be a while ago, the mission entrusted by industry-academia collaboration S'J R R Sasai was completed in 5 years. RJA is attracting companies to the "Integrated Collaboration Innovative Am Building" The two companies gathered only through joint research with Tsuji, and the external funds acquired by S reached 10% of the total joint research expenses that RIKEN received from the companies. .. It is also an initiative aimed at the pre-war RIKEN that can be operated independently. Aiming at the practical application of regenerative medicine for hair follicles RIKEN and Organ Co., Ltd., which has been approved as an e-love launcher that applies the seeds, formed a tie-up with Tsuji, who resonated with R°moriism at Kyozeto. , Won the contract directly with the founder, Kazuo Inamori, and won the contract. Pioneered the world's first artificial skin for evaluating functionality. As the trend of banning animal experiments progresses, it is drawing attention as the next-generation artificial skin. "Hair Diagnosis" is aimed at commercialization of the law. RIKEN promotes advanced research, 20 organizations such as organ Co., Ltd., which originates in collaboration with private companies, and Yahoo established Consortium A, and joint research has started. About 100 hair follicles collected from 1 scalp. Cultivate to produce more than 5,000 hair follicles, equivalent to 10,000 hairs. In an experiment in which this was transplanted to a mouse, hair was regenerated and regenerated for a lifetime. There are great expectations not only for androgen alopecia but also for treatment of intractable alopecia such as congenital alopecia. On the other hand, for the regeneration of teeth, we are developing a next-generation "hybrid implant" with Kasugai of Tokyo Medical and Dental University and Masamitsu Oshima, an associate professor of Tokushima University who is a disciple of Tsuji. Treatment, which connects artificial teeth to alveolar bone to compensate for tooth loss, is widely used, but it cannot be said to be a cure. The artificial tooth is connected to the alveolar bone through the human HS periodontal ligament to reproduce the same physiological function as a natural tooth. Artificial teeth do not become caries and have the advantage of organ regeneration while strengthening their functions. It has been successful in experiments on dogs with strong success, and is aiming for early commercialisation. Tsuji, who is particular about useful research, has consistently pursued social implementation. "Innovation from innovative basic research will lead to the development of health and medical care in Japan and the promotion of Japanese industry. Its realization is its mission." There is a total of endless dreams = honorifics omitted. After working as a reporter for the Yomiuri Shimbun, Asako Tsukazaki became independent. Many authors in the medical field. Master of Science, University of Tsukuba and Tokyo Medical and Dental University. Leading authors: "Japanese medicine that saved the world" "Japanese scientists who challenged new drugs"
This treatment is way too expensive. I hope there is some serious competition that I am not aware of. What was the price they were aiming for this treatment? Something like $250,000, right? This is for rich ppl only sadly. Is there any other company in a similar stage of reaserch or just Tsuji has a chance in the next years to find a cure?
There are several others, but only Tsuji/RIKEN and Tissuse are trying to commercialize in Japan where it can realistically be expected to gain regulatory approval this decade.
This turns me off getting a transplant. The scars are so obvious, and I would need far more grafts than you.
The fact that people are concerned about a price of a cure or a treatment that it not even here yet and nobody knows when it will be, is really beyond me.
I cant really shake the fact that Tsuji has been heralded as the savior really not because he came up with a "cure" necessarily lots of companies have had bold claims over the years but because so far as we knew he and Riken were on schedule. They were going to make it in 2020 and all the updates suggested so right up until the end of 2019 of course when it f*****g counted and then they reminded us that this research was in the hair loss area and nothing comes to fruition ever. I was on the hype train until then when I realized i was wrong and the people who are pessimistic are that way for a reason... they use actual data.
Yeah but you might be lucky like Kambrira159, who says he had more than 2,000 grafts FUE, he "can't tell sh*t when it's buzzed"! Wish Kambrira159 would reveal the name of his magic surgeon so we could all go there.
